[go: up one dir, main page]

MX170801B - Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles - Google Patents

Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles

Info

Publication number
MX170801B
MX170801B MX016734A MX1673489A MX170801B MX 170801 B MX170801 B MX 170801B MX 016734 A MX016734 A MX 016734A MX 1673489 A MX1673489 A MX 1673489A MX 170801 B MX170801 B MX 170801B
Authority
MX
Mexico
Prior art keywords
prevention
pharmaceutical composition
sexually
communicable diseases
est
Prior art date
Application number
MX016734A
Other languages
English (en)
Inventor
Jacques Julien Augros
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Publication of MX170801B publication Critical patent/MX170801B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a composición farmacéutica para la prevención de las enfermedades sexualmente transmisibles (EST") destinada para ser puesta en contacto con una mucosa, caracterizada porque incluye, por una parte por lo menos un principio activo contra virus o bacterias responsables de las mensionadas EST y, por otra parte, un producto inhibidor de penetración de dicho principio activo a traves de la mucusa, en combinación con un vehículo farmaceuticamente aceptable adaptado para una administración por vía tópica de esta composición.
MX016734A 1988-07-11 1989-07-10 Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles MX170801B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
MX170801B true MX170801B (es) 1993-09-14

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
MX016734A MX170801B (es) 1988-07-11 1989-07-10 Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles

Country Status (38)

Country Link
US (1) US5439685A (es)
EP (1) EP0351301B1 (es)
JP (1) JPH0774164B2 (es)
KR (1) KR0143231B1 (es)
CN (1) CN1035038C (es)
AP (1) AP108A (es)
AR (1) AR243381A1 (es)
AT (1) ATE97570T1 (es)
BR (1) BR8903523A (es)
CA (1) CA1341304C (es)
CZ (1) CZ280722B6 (es)
DD (1) DD283932A5 (es)
DE (1) DE68910892T2 (es)
DK (1) DK173527B1 (es)
ES (1) ES2062065T3 (es)
FI (1) FI101595B (es)
HK (1) HK131095A (es)
HU (1) HU206634B (es)
IE (1) IE63115B1 (es)
IL (1) IL90910A (es)
LT (1) LT3754B (es)
LV (1) LV10573B (es)
MA (1) MA22036A1 (es)
MD (1) MD406C2 (es)
MX (1) MX170801B (es)
MY (1) MY106242A (es)
NO (1) NO178843C (es)
NZ (1) NZ229891A (es)
OA (1) OA09123A (es)
PL (1) PL161848B1 (es)
PT (1) PT91108B (es)
RU (1) RU2065742C1 (es)
SK (1) SK423889A3 (es)
TN (1) TNSN89074A1 (es)
TR (1) TR28353A (es)
UA (1) UA26124A (es)
YU (1) YU47899B (es)
ZA (1) ZA895263B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
CA2167537A1 (en) * 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
GB2318292A (en) * 1996-09-12 1998-04-22 Simon Everard Barton Saliva-like protectants
US6287286B1 (en) * 1998-08-25 2001-09-11 Kimberly-Clark Worldwide, Inc. Absorbent article having a reduced viability of candida albicans
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
FR2803208A1 (fr) * 1999-12-29 2001-07-06 Jean Bastien Pasquini Tampon periodique antiseptique et son procede de preparation
PL202918B1 (pl) * 2000-03-07 2009-08-31 Rush Presbyterian St Luke Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
GB2412121B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Tampon with malodour counteractant
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
SE0102152L (sv) * 2001-06-18 2002-12-19 Sca Hygiene Prod Ab Ny produkt
EP1506781B1 (de) * 2003-11-03 2005-02-23 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
AP2626A (en) * 2005-08-29 2013-03-26 Sepsicure Llc Method for treatment or prevention of conditions caused by gram-positive bacteria
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
US9078813B2 (en) 2010-11-12 2015-07-14 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR20140050608A (ko) 2011-04-19 2014-04-29 암즈 파머수티컬 엘엘씨 유해 미생물 저해 방법 및 그를 위한 장벽-형성 조성물
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
DE102020131233A1 (de) * 2020-11-25 2022-05-25 Netzsch Trockenmahltechnik Gmbh Verfahren zur herstellung eines homogenisierten gemischs aus kohlenstoff, schwefel und ptfe
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (es) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
EP0081370A1 (en) * 1981-12-07 1983-06-15 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
AU625716B2 (en) 1992-07-16
FI101595B1 (fi) 1998-07-31
AR243381A1 (es) 1993-08-31
BR8903523A (pt) 1991-11-05
RU2065742C1 (ru) 1996-08-27
TR28353A (tr) 1996-05-16
MY106242A (en) 1995-04-29
KR0143231B1 (ko) 1998-07-15
AP8900133A0 (en) 1989-10-31
EP0351301A2 (fr) 1990-01-17
DK340289D0 (da) 1989-07-10
DK340289A (da) 1990-01-12
NZ229891A (en) 1991-01-29
NO892826D0 (no) 1989-07-07
FI101595B (fi) 1998-07-31
TNSN89074A1 (fr) 1991-02-04
CZ280722B6 (cs) 1996-04-17
LTIP1660A (en) 1995-07-25
CA1341304C (fr) 2001-10-09
ZA895263B (en) 1991-03-27
HUT50445A (en) 1990-02-28
MD406C2 (ro) 1996-06-30
PL280531A1 (en) 1990-05-28
JPH0774164B2 (ja) 1995-08-09
IL90910A0 (en) 1990-02-09
FI893340L (fi) 1990-01-12
OA09123A (fr) 1991-10-31
LV10573A (lv) 1995-04-20
AU3802689A (en) 1990-01-11
SK278614B6 (en) 1997-11-05
CZ423889A3 (en) 1995-12-13
LT3754B (en) 1996-03-25
DE68910892T2 (de) 1994-05-05
EP0351301B1 (fr) 1993-11-24
IE892218L (en) 1990-01-11
PL161848B1 (pl) 1993-08-31
YU47899B (sh) 1996-05-20
EP0351301A3 (en) 1990-12-19
NO178843C (no) 1996-06-19
HK131095A (en) 1995-08-24
CN1041879A (zh) 1990-05-09
DD283932A5 (de) 1990-10-31
ES2062065T3 (es) 1994-12-16
FI893340A0 (fi) 1989-07-10
NO892826L (no) 1990-01-12
ATE97570T1 (de) 1993-12-15
DK173527B1 (da) 2001-01-29
HU206634B (en) 1992-12-28
LV10573B (en) 1995-08-20
PT91108B (pt) 1995-01-31
DE68910892D1 (de) 1994-01-05
MA22036A1 (fr) 1991-10-01
NO178843B (no) 1996-03-11
JPH02167235A (ja) 1990-06-27
PT91108A (pt) 1990-02-08
UA26124A (uk) 1999-06-07
AP108A (en) 1991-02-23
KR900001366A (ko) 1990-02-27
IL90910A (en) 1994-12-29
SK423889A3 (en) 1997-11-05
US5439685A (en) 1995-08-08
YU135789A (en) 1992-05-28
IE63115B1 (en) 1995-03-22
CN1035038C (zh) 1997-06-04

Similar Documents

Publication Publication Date Title
MX170801B (es) Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles
KR100761051B1 (ko) 점막염, 구내염 및 베체트 증후군 치료용 약학적 조성물
EP0679390A3 (en) Sprayable topical pharmaceutical compositions
CA2333869A1 (en) Mousse composition
CA2304958A1 (en) Bioadhesive compositions and methods for topical administration of active agents
WO1999053897A3 (en) Topical formulation comprising poloxamers and further microbicides, and an applicator
CA2293470A1 (en) Benzimidazole derivatives
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
CA2219065A1 (en) Ophthalmic carrier solution
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
GR3032116T3 (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
BR9803233A (pt) Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares.
CA2294448A1 (en) Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
EP0343631A3 (en) Preventing agent for human immunodeficiency virus infection comprising menfegol
WO1994027584A3 (en) Arylating medicaments
WO2001019357A3 (de) Kombinationspräparat zur behandlung von sexueller dysfunktion
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
WO2004033479A3 (en) Retroyclins: antiviral and antimicrobial peptides
MY110074A (en) Pharmacuetical formulation.
EP0385909A3 (en) A kit or composition for the prevention or treatment of HIV-1 infections
WO2001070184A3 (en) A composition containing monoterpenes for topical oral administration
AU4040195A (en) Topical composition containing penciclovir
KR910004186A (ko) 제약학적 배합물